Tarsons Products Ltd
NSE:TARSONS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tarsons Products Ltd
NSE:TARSONS
|
IN |
|
W
|
Westpac Banking Corp
NZX:WBC
|
AU |
|
RadioIO Inc
OTC:RAIO
|
US |
|
F
|
Fima Corporation Bhd
KLSE:FIMACOR
|
MY |
|
Z
|
Zevra Therapeutics Inc
NASDAQ:ZVRA
|
US |
Tarsons Products Ltd
Tarsons Products Ltd. engages in the production and supply of laboratory plastic ware for use within molecular biology, cell culture, genomics, proteomics and immunology. The company is headquartered in Kolkata, West Bengal and currently employs 556 full-time employees. The company went IPO on 2021-11-26. The firm is engaged in the designing, development, manufacturing and marketing of consumables, reusables and others including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, contract research organizations (CROs), diagnostic companies and hospitals. The company manufactures a range of labware products which helps scientific discovery and healthcare. Its product portfolio is classified into three categories which include consumables, reusables, and others. Its Consumables category includes products such as centrifuge ware, cryogenic ware, liquid handling, petri dish, transfer pipettes and others. Its Reusables category includes products such as bottles, carboys, beakers, measuring cylinders and tube racks. The firm's Others category includes benchtop instrumentation such as vortex shakers, and centrifuges pipettors.
Tarsons Products Ltd. engages in the production and supply of laboratory plastic ware for use within molecular biology, cell culture, genomics, proteomics and immunology. The company is headquartered in Kolkata, West Bengal and currently employs 556 full-time employees. The company went IPO on 2021-11-26. The firm is engaged in the designing, development, manufacturing and marketing of consumables, reusables and others including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, contract research organizations (CROs), diagnostic companies and hospitals. The company manufactures a range of labware products which helps scientific discovery and healthcare. Its product portfolio is classified into three categories which include consumables, reusables, and others. Its Consumables category includes products such as centrifuge ware, cryogenic ware, liquid handling, petri dish, transfer pipettes and others. Its Reusables category includes products such as bottles, carboys, beakers, measuring cylinders and tube racks. The firm's Others category includes benchtop instrumentation such as vortex shakers, and centrifuges pipettors.
Revenue Growth: Tarsons reported Q3 revenue growth of 12.8% year-on-year at both standalone and consolidated levels, reflecting recovering demand.
Profitability: Adjusted profit after tax for Q3 rose 21.4% year-on-year after accounting for one-time labor code expenses. Cash PAT saw an even stronger increase.
Margins: EBITDA margin improved to 34.7% for Q3 and 32.9% for 9M FY'26 on a standalone basis, with consolidated Q3 EBITDA margin at 29.2%.
Capacity Expansion: New capacities, especially in bioprocess and cell culture products, are coming online, but utilization remains low; ramp-up is expected over the next few years.
Competitive Pressures: Domestic market competition has intensified post-COVID, leading to aggressive pricing and margin pressure.
Exports & Trade Agreements: Recent trade agreements with the US and EU are expected to boost export competitiveness, especially if tariffs are reduced.
Nerbe Performance: Nerbe, the European subsidiary, saw a 22% sales increase, mainly due to currency effects rather than volume growth, amid a weak European market.
